Skip to main content

Year: 2019

Equinor ASA: Notifiable trading

On behalf of Equinor (OSE: EQNR, NYSE: EQNR), DNB has on 10 December 2019 purchased 625,599 shares for use in the group’s Share saving plan.The shares have been acquired at a price of NOK 168.34 per share.Before distribution to the employees, the Share saving plan has 10,409,267 shares.This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Continue reading

Equinor ASA: Meldepliktig handel

På vegne av Equinor (OSE: EQNR, NYSE: EQNR) har DNB 10. desember 2019 kjøpt 625.599 aksjer til bruk i Equinors aksjespareprogram.Aksjene er kjøpt til kurs 168,34 kroner. Før viderefordeling til ansatte har Aksjespareprogrammet 10.409.267 aksjer.Denne opplysningen er informasjonspliktig etter verdipapirhandelloven §5-12

Continue reading

eXp Realty Selected As a Best Place to Work For Third Consecutive Year

BELLINGHAM, Wash., Dec. 10, 2019 (GLOBE NEWSWIRE) — eXp Realty, the largest residential real estate brokerage by geography in North America and a subsidiary of eXp World Holdings, Inc. (NASDAQ: EXPI), was named as a best place to work for a third consecutive year in Glassdoor’s 2020 Employees’ Choice Awards among U.S. large businesses.The award is based solely on anonymous employee feedback via Glassdoor, where employees rate their satisfaction with the company overall and key workplace factors, including career opportunities, compensation and benefits, culture and values, senior management and work/life balance. Currently on Glassdoor, eXp Realty has an overall rating of 4.4 out of five stars.Additional highlights on eXp Realty’s Glassdoor profile include:88 percent of employees would recommend eXp Realty to a friendEmployees rank...

Continue reading

Madrigal Pharmaceuticals Announces Pricing of Secondary Offering

WEST CONSHOHOCKEN, Pa., Dec. 10, 2019 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) (“Madrigal” or the “Company”), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases, today announced the pricing of the previously-announced underwritten secondary offering by investment funds affiliated with Bay City Capital LLC, of 1,200,000 shares of Madrigal’s common stock at the public offering price of $107.85 per share. In connection with the offering, the selling stockholders have granted the underwriter an option, exercisable for 30 days after December 10, 2019, to purchase up to 180,000 additional shares of common stock, at the public offering price, less underwriting discounts,...

Continue reading

Meetings Resume with Independent Mediators and USW

VANCOUVER, British Columbia, Dec. 10, 2019 (GLOBE NEWSWIRE) — Western Forest Products Inc. (TSX: WEF) (“Western” or the “Company”) announced today that the Company and the United Steelworkers Local 1-1937 (“USW”) will meet with independent mediators Vince Ready and Amanda Rogers this week. The parties have agreed to a media blackout during this mediation process.The strike, which commenced on July 1, 2019, affects all the Company’s USW certified manufacturing and timberlands operations in British Columbia, impacting approximately 1,500 of the Company’s hourly employees and approximately 1,500 employees working for the Company’s timberland operations and contractors.About Western Forest Products Inc.Western is an integrated forest products company building a margin-focused log and lumber business to compete successfully in global...

Continue reading

Constellation Pharmaceuticals Announces Pricing of Public Offering of Common Stock

CAMBRIDGE, Mass., Dec. 10, 2019 (GLOBE NEWSWIRE) — Constellation Pharmaceuticals, Inc., (Nasdaq: CNST) a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced that it has priced an underwritten public offering of 6,500,000 shares of its common stock at a public offering price of $34.50 per share, for total gross proceeds of $224.3 million, before deducting underwriting discounts and commissions and expenses payable by Constellation. All of the shares in the offering are being sold by Constellation. In addition, Constellation has granted the underwriters a 30-day option to purchase up to 975,000 additional shares of its common stock at the public offering price, less the underwriting discount and commissions. The offering is expected to close on December...

Continue reading

Willis Towers Watson Announces Regular Quarterly Dividend

ARLINGTON, Va. and LONDON, Dec. 10, 2019 (GLOBE NEWSWIRE) — Willis Towers Watson (NASDAQ: WLTW), a leading global advisory, broking and solutions company, announced that it approved a regular quarterly cash dividend of $0.65 per ordinary share for the quarter ended September 30, 2019. The dividend is payable on or around January 15, 2020 to shareholders of record at the close of business on December 31, 2019.About Willis Towers Watson

Continue reading

BRP et ses actionnaires principaux annoncent un reclassement par voie de prise ferme de 305 850 000$ CA

VALCOURT, Québec, 10 déc. 2019 (GLOBE NEWSWIRE) — BRP inc. (TSX : DOO) (NASDAQ : DOOO) (« BRP » ou la « Société ») a annoncé aujourd’hui que certains de ses actionnaires, notamment Beaudier Inc. et 4338618 Canada Inc. (collectivement, le « groupe Beaudier »), Bain Capital Luxembourg Investments S.à r.l. (« Bain ») (les « actionnaires vendeurs ») et la Société ont conclu une convention avec un syndicat de prise ferme dirigé par BMO Marchés des capitaux, Citigroup et RBC Marchés des Capitaux afin de réaliser un reclassement par voie de prise ferme (le « placement »). Aux termes de la convention, les preneurs fermes ont convenu d’acheter 5 000 000 d’actions à droit de vote subalterne de la Société au prix de 61,17 $ chacune, ce qui rapportera aux actionnaires vendeurs un produit brut total de 305 850 000 $ CA.En vue du placement, la...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.